Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction Between D797 (Donepezil) and D324 (Memantine)
NCT03569579Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Apr 2018
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil and memantine in Alzheimer's disease (AD) (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Area Under the Curve to the last measurable concentration at 216 hours and Maximum Plasma Concentration at 216 hours. Started Apr 2018; status: completed.
02
Drugs
donepezilmemantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03569579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03569579.